ID2 protects retinal pigment epithelium cells from oxidative damage through p-ERK1/2/ID2/NRF2

Archives of Biochemistry and Biophysics
Yuting FanHuangxuan Shen

Abstract

Age-related macular degeneration (AMD) is the leading cause of blindness during aging. The degeneration of retinal pigment epithelium (RPE) is the main pathologic characteristic of AMD. ID2 is a member of the Inhibitor of DNA binding proteins (ID) family and is involved in regulation of cell proliferation and differentiation. However, currently the role of ID2 in oxidative injury response in RPE cells remains unknown. Here we showed that oxidative stress increased ID2 expression in RPE cells. Knockdown of ID2 promoted cell apoptosis and increased ROS level in RPE cells that were subjected to oxidative damage. In addition, over-expression of ID2 attenuated the oxidative damage response in RPE cells. Mechanistically, ID2 protected RPE cells from oxidative damage through activating NRF2. Furthermore, phosphorylation of ERK1/2 positively regulated the protective function of ID2. Finally, we confirmed that the oxidative damage increased Id2 expression and over-expression of Id2 elevated Nrf2 expression in primary mouse RPE cells. Therefore, ID2 protects RPE cells from oxidative damage through the p-ERK1/2/ID2/NRF2 pathway. Our study contributes to a better understanding of the mechanisms underlying oxidative stress in AMD and may pr...Continue Reading

References

Feb 12, 2005·Antioxidants & Redox Signaling·Makoto Kobayashi, Masayuki Yamamoto
Aug 24, 2005·Proceedings of the National Academy of Sciences of the United States of America·Gennadiy MoiseyevJian-Xing Ma
Feb 6, 2008·The Veterinary Clinics of North America. Small Animal Practice·David L Williams
May 1, 2010·Trends in Biochemical Sciences·Robert B Hamanaka, Navdeep S Chandel
Jan 11, 2011·The Journal of Biological Chemistry·Monica Carvajal-YepesEberhard Hildt
Dec 6, 2011·Global Public Health·Adam GordoisKathleen Chua
Sep 12, 2012·Nucleic Acids Research·Yosuke HirotsuMasayuki Yamamoto
Dec 29, 2012·Frontiers in Oncology·Yoichiro MitsuishiMasayuki Yamamoto
Jan 9, 2013·Annual Review of Pharmacology and Toxicology·Qiang Ma
Oct 10, 2013·The Journal of Pathology·Menno van Lookeren CampagneWeilan Ye
Nov 30, 2013·Nature Reviews. Drug Discovery·Chiara GorriniTak W Mak
Mar 22, 2014·Trends in Biochemical Sciences·John D Hayes, Albena T Dinkova-Kostova
Oct 3, 2014·Cardiovascular Research·Jun YangNicholas W Morrell
Sep 8, 2015·Progress in Retinal and Eye Research·Deborah A FerringtonKai Kaarniranta
Feb 18, 2016·Oxidative Medicine and Cellular Longevity·María Luisa Fanjul-Moles, Germán Octavio López-Riquelme
Jun 10, 2016·Nature Protocols·Rosario Fernandez-GodinoEric A Pierce
Jan 13, 2017·The EMBO Journal·Lira NigmatullinaNatalia Soshnikova
Feb 15, 2017·Oxidative Medicine and Cellular Longevity·Tomomi MasudaHideaki Hara
Mar 23, 2017·BioMed Research International·Jia HeHuangxuan Shen
Mar 25, 2017·Progress in Retinal and Eye Research·Sayantan DattaJames T Handa
Sep 21, 2017·Immunity·Mengxi Sun, Barbara L Kee
Jan 13, 2018·Experimental Physiology·Jia-Pu WangBian-Ai Fan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis